ELF4 and neoplasm: The circZNF451/FXR1/ELF4/IRF4 axis reshapes the tumor immune microenvironment by inducing the polarization of M2 macrophages, which subsequently inhibits the sensitivity of anti-programmed death-1 (PD-1) therapy in lung adenocarcinoma.